In recent studies, a novel subset of MDSCs were identified based on the presence of CD14 expression but the absence of human leukocyte antigen (HLA)-DR expression (CD14+HLA-DR−) in the peripheral blood of cancer patients, including those with lung cancer and head and neck SCC [13-15]. This evidence concerns the gene CD14 and lung carcinoma.